Aldeyra Therapeutics Announces Positive Results From Phase II Clinical Trial in Subjects With Noninfectious Anterior Uveitis

Go back to Aldeyra Therapeutics Announces Positive Results From Phase II Clinical Trial in Subjects With Noninfectious Anterior Uveitis
ALDEYRA THERAPEUT (NASDAQ: ALDX) Delayed: 2.02 -0.03 (1.46%)
Previous Close $2.05    52 Week High $8.19 
Open $2.00    52 Week Low $3.39 
Day High $2.21    P/E N/A 
Day Low $2.00    EPS $0.00 
Volume 2,434,640       

ShangPharma Corp. ADS (NYSE: SHP) Delayed: 8.95 --0 (-0%)
Previous Close $8.95    52 Week High $26.30 
Open $8.95    52 Week Low $26.03 
Day High $8.95    P/E N/A 
Day Low $8.95    EPS $0.00 
Volume 1,942,335       

Shire pic (NASDAQ: SHPG) Delayed: 179.20 +101.90 (131.82%)
Previous Close $77.30    52 Week High $219.52 
Open $77.29    52 Week Low $147.60 
Day High $77.49    P/E N/A 
Day Low $179.20    EPS $0.00 
Volume 302,425